Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Aug 19:28:101685.
doi: 10.1016/j.ajoc.2022.101685. eCollection 2022 Dec.

Therapeutic Hyper-CL soft contact lens in Sjögren's syndrome

Vito Romano  1 , Davide Romano  1 , Paolo Semeraro  2 , Eliana Forbice  1 , Antonio Iaria  1 , Teodoro Pizzolante  1 , Micol Frassi  2 , Franco Franceschini  2 , Francesco Semeraro  1
Affiliations
Case Reports

Therapeutic Hyper-CL soft contact lens in Sjögren's syndrome

Vito Romano et al. Am J Ophthalmol Case Rep. .

Abstract

Purpose: To report increased corneal bioavailability of allogenic serum when used in combinations with Therapeutic Hyper-CL™ soft contact lens in a patient with severe Sjögren's syndrome-associated dry eye.

Observations: A 57-year-old woman with a medical history of bilateral severe Sjögren's syndrome-associated dry eye and previous amniotic membrane patch for autoimmune corneal perforation in her left eye was referred for left eye recurrence of progressive melting and pending perforation. After manual corneal trephination, full thickness transplant and sutured amniotic membrane patch, a Therapeutic Hyper-CL™ soft contact lens (EyeYon Medical, Ness Tziona, Israel) was fit. The patient was commenced in the left eye with topical corticosteroid, antibiotic, and allogenic serum eye drops. In the right eye the patient had silicone hydrogel bandage contact lens and was under same treatment of the left eye for previous endothelial keratoplasty. In order to evaluate the efficacy and increased corneal availability of drugs provided by Therapeutic Hyper-CL™ compared with silicone hydrogel soft contact lens, anterior segment OCT was performed.

Conclusions and importance: The anterior segment OCT showed a thicker meniscus of fluid and possibly subsequent increase of trophic factors bioavailability in left eye compared with right eye. Therefore, in case of severe and refractory dry-eye disease the combination of Therapeutic Hyper-CL™ and serum eye drops may be representing a valid therapeutic approach.

Keywords: AM, amniotic membrane; Cornea; Hyper-cl; SS, Sjögren's syndrome; Serum eye; Sjogren; allo-SED, allogenic serum eye drops; auto-SED, autologous serum eye drops; dry eye.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Anterior segment photo of the right eye at time of the referral.
Fig. 2
Fig. 2
Anterior segment photo of the left eye at time of the referral.
Fig. 3
Fig. 3
Anterior segment OCT of the left eye at time of the referral, positive for pending perforation.
Fig. 4
Fig. 4
A and B: Anterior segment photos of the left eye at follow-up (A) with intact corneal epithelium at fluo-test (B).
Fig. 4
Fig. 4
A and B: Anterior segment photos of the left eye at follow-up (A) with intact corneal epithelium at fluo-test (B).
Fig. 5
Fig. 5
Anterior segment OCT of the right eye with the fluid meniscus thickness provided by standard bandage contact lens.
Fig. 6
Fig. 6
Anterior segment OCT of the left eye with the fluid meniscus thickness provided by Therapeutic Hyper-CLTM
Fig. 7
Fig. 7
Therapeutic Hyper-CL™ lens.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kassan S.S., Moutsopoulos H.M. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004;164(12):1275. doi: 10.1001/archinte.164.12.1275. - DOI - PubMed
    1. Akpek E.K., Bunya V.Y., Saldanha I.J. Sjögren’s syndrome: more than just dry eye. Cornea. 2019;38(5):658–661. doi: 10.1097/ICO.0000000000001865. - DOI - PMC - PubMed
    1. Brunner M., Romano V., Steger B., et al. Imaging of corneal neovascularization: optical coherence tomography angiography and fluorescence angiography. Investig Ophthalmol Vis Sci. 2018;59(3):1263–1269. doi: 10.1167/iovs.17-22035. - DOI - PubMed
    1. Liu S., Romano V., Steger B., et al. Gene-based antiangiogenic applications for corneal neovascularization. Surv Ophthalmol. 2018;63(2):193–213. doi: 10.1016/j.survophthal.2017.10.006. - DOI - PubMed
    1. Foulks G.N., Forstot S.L., Donshik P.C., et al. Clinical guidelines for management of dry eye associated with sjögren disease. Ocul Surf. 2015;13(2):118–132. doi: 10.1016/j.jtos.2014.12.001. - DOI - PubMed

Publication types

LinkOut - more resources